Nereus Message Board - Msg: 22760104

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nereus

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Mike McFarland	8/28/2006 9:05:40 PM
	Read Replies (2) of 19

papers from 2005 and 2006 that show up at Pubmed: Discovery of novel metabolites from marine actinomycetes. Curr Opin Microbiol. 2006 Jun;9(3):245-51. NPI-2358 is a tubulin-depolymerizing agent: in-vitro evidence for activity as a tumor vascular-disrupting agent. Anticancer Drugs. 2006 Jan;17(1):25-31. Glaciapyrroles A, B, and C, pyrrolosesquiterpenes from a Streptomyces sp. isolated from an Alaskan marine sediment. J Nat Prod. 2005 May;68(5):780-3. Structure-activity relationship studies of salinosporamide A (NPI-0052), a novel marine derived proteasome inhibitor. J Med Chem. 2005 Jun 2;48(11):3684-7. Lajollamycin, a nitro-tetraene spiro-beta-lactone-gamma- lactam antibiotic from the marine actinomycete Streptomyces nodosus. J Nat Prod. 2005 Feb;68(2):240-3. A new family of synthetic diterpenes that regulates cytokine synthesis by inhibiting IkappaBalpha phosphorylation. Chembiochem. 2005 Jan;6(1):133-44. Here is their publications page, looks like it is only up to date through 2003: nereuspharm.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next